{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:43:23Z","timestamp":1791229403572,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.urology.2017.09.005","type":"journal-article","created":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T01:02:03Z","timestamp":1506042123000},"page":"168-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Clinical and Urodynamic Results of Repeated Intradetrusor Onabotulinum Toxin A Injections in Refractory Neurogenic Detrusor Overactivity: Up to 5 Injections in a Cohort of Children With Myelodysplasia"],"prefix":"10.1016","volume":"111","author":[{"given":"Cagri Akin","family":"Sekerci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiloren","family":"Tanidir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asgar","family":"Garayev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem","family":"Akbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tufan","family":"Tarcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferruh","family":"Simsek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2017.09.005_bib0010","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.eururo.2005.12.056","article-title":"Early start to therapy preserves kidney function in spina bifida patients","volume":"49","author":"Dik","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2017.09.005_bib0015","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/01.ju.0000108892.35041.2d","article-title":"Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia","volume":"171","author":"Riccabona","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.09.005_bib0020","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0022-5347(01)68162-X","article-title":"Intravesical capsaicin as a treatment for refractory detrusor hyperreflexia: a dual center study with long-term followup","volume":"158","author":"De Ridder","year":"1997","journal-title":"J Urol"},{"issue":"2 Pt 2","key":"10.1016\/j.urology.2017.09.005_bib0025","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0022-5347(17)38798-0","article-title":"Bladder autoaugmentation: early clinical experience","volume":"142","author":"Cartwright","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.09.005_bib0030","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/S0022-5347(05)65183-X","article-title":"Intravesical capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: a prospective randomized study","volume":"167","author":"Giannantoni","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.09.005_bib0035","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/sc.1994.126","article-title":"The first 500 patients with sacral anterior root stimulator implants: general description","volume":"32","author":"Brindley","year":"1994","journal-title":"Spinal Cord"},{"key":"10.1016\/j.urology.2017.09.005_bib0040","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","article-title":"Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results","volume":"164","author":"Schurch","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.09.005_bib0045","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.eururo.2004.11.009","article-title":"Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence","volume":"47","author":"Grosse","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2017.09.005_bib0050","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1464-410X.2007.06977.x","article-title":"Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction","volume":"100","author":"Akbar","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2017.09.005_bib0055","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4111\/kju.2014.55.4.281","article-title":"Intradetrusor injections of onabotulinum toxin-A in children with urinary incontinence due to neurogenic detrusor overactivity refractory to antimuscarinic treatment","volume":"55","author":"Tarcan","year":"2014","journal-title":"Korean J Urol"},{"key":"10.1016\/j.urology.2017.09.005_bib0060","article-title":"Is 40\u2009cm H2O detrusor leak point pressure cut-off reliable for upper urinary tract protection in children with myelodysplasia?","author":"Tarcan","year":"2016","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2017.09.005_bib0065","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/nau.22546","article-title":"International Continence Society guidelines on urodynamic equipment performance","volume":"33","author":"Gammie","year":"2014","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2017.09.005_bib0070","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/nau.10066","article-title":"Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies","volume":"21","author":"Sch\u00e4fer","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2017.09.005_bib0075","article-title":"The standardization of terminology of lower urinary tract function in children and adolescents: update report from the standardization committee of the International Children's Continence Society","author":"Austin","year":"2015","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2017.09.005_bib0080","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00383-013-3365-x","article-title":"Repeated injections of intradetrusor onabotulinumtoxina as adjunctive treatment of children with neurogenic bladder","volume":"30","author":"Sager","year":"2014","journal-title":"Pediatr Surg Int"},{"key":"10.1016\/j.urology.2017.09.005_bib0085","doi-asserted-by":"crossref","first-page":"94.e1","DOI":"10.1016\/j.jpurol.2015.06.019","article-title":"Ten years of experience with intravesical and intrasphincteric onabotulinum toxin A in children","volume":"12","author":"Greer","year":"2016","journal-title":"J Pediatr Urol"},{"key":"10.1016\/j.urology.2017.09.005_bib0090","doi-asserted-by":"crossref","first-page":"104.e1","DOI":"10.1016\/j.jpurol.2015.08.018","article-title":"Botulinum toxin injection in the pediatric population with medically refractory neuropathic bladder","volume":"12","author":"Khan","year":"2016","journal-title":"J Pediatr Urol"},{"key":"10.1016\/j.urology.2017.09.005_bib0095","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/nau.21248","article-title":"Intradetrusor botulinum neurotoxin A (BoNT-A) injections decrease bladder fibrosis secondary to partial urethral obstruction in the male rat model","volume":"31","author":"Tinay","year":"2012","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2017.09.005_bib0100","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.urology.2003.12.007","article-title":"Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents","volume":"63","author":"Kuo","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.urology.2017.09.005_bib0105","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/nau.20105","article-title":"Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity?","volume":"24","author":"Kessler","year":"2005","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2017.09.005_bib0110","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.eururo.2010.09.007","article-title":"Adverse events of intravesical botulinum toxin a injections for idiopathic detrusor overactivity: risk factors and influence on treatment outcome","volume":"58","author":"Kuo","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2017.09.005_bib0115","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.eururo.2005.06.021","article-title":"Botulinum-A toxin detrusor and sphincter injection in treatment of overactive bladder syndrome: objective outcome and patient satisfaction","volume":"48","author":"Schulte-Baukloh","year":"2005","journal-title":"Eur Urol"},{"issue":"3 Pt 1","key":"10.1016\/j.urology.2017.09.005_bib0120","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/S0022-5347(05)00400-3","article-title":"Repeated intradetrusor botulinum toxin type A in children with neurogenic bladder due to myelomeningocele","volume":"175","author":"Altaweel","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.09.005_bib9000","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/ana.20098","article-title":"Clinical impact of antibody formation to botulinum toxin A in children","volume":"55","author":"Herrmann","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.urology.2017.09.005_bib0125","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/j.1464-410X.2009.08600.x","article-title":"Long-term effects of repeated intradetrusor botulinum neurotoxin A injections on detrusor function in patients with neurogenic bladder dysfunction","volume":"104","author":"Pannek","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2017.09.005_bib0130","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s12325-013-0054-z","article-title":"Onabotulinum toxin A is effective in patients with urinary incontinence due to neurogenic detrusor overactivity [corrected] regardless of concomitant anticholinergic use or neurologic etiology","volume":"30","author":"Ginsberg","year":"2013","journal-title":"Adv Ther"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429517309810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429517309810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T13:35:28Z","timestamp":1530279328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429517309810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":26,"alternative-id":["S0090429517309810"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2017.09.005","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and Urodynamic Results of Repeated Intradetrusor Onabotulinum Toxin A Injections in Refractory Neurogenic Detrusor Overactivity: Up to 5 Injections in a Cohort of Children With Myelodysplasia","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2017.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}